Anna Scomparin
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery 12
- Pharmaceutical Science top 2%
- Advanced Drug Delivery Systems 5
- Immunology top 10%
- Immunotherapy and Immune Responses 8
- Biomedical Engineering top 5%
- Nanoplatforms for cancer theranostics 10
- Graphene and Nanomaterials Applications 4
- Molecular Medicine top 10%
-
- RNA Interference and Gene Delivery 19
- Advanced biosensing and bioanalysis techniques 16
- DNA and Nucleic Acid Chemistry 3
Anna Scomparin
46 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 116
- Biomaterials 595
- Pharmaceutical Science 160
- Immunology 299
- Biomedical Engineering 607
- Molecular Medicine 62
Countries citing papers authored by Anna Scomparin
This map shows the geographic impact of Anna Scomparin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Scomparin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Scomparin more than expected).
Fields of papers citing papers by Anna Scomparin
This network shows the impact of papers produced by Anna Scomparin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Scomparin. The network helps show where Anna Scomparin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Anna Scomparin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 2 | |
| 4 | 2023 | 28 | |
| 5 | 2022 | 10 | |
| 6 | 2021 | 12 | |
| 7 | 2021 | 48 | |
| 8 | 2020 | 43 | |
| 9 | 2019 | 187 | |
| 10 | 2019 | 72 | |
| 11 | 2019 | 41 | |
| 12 | 2019 | 9 | |
| 13 | 2019 | 61 | |
| 14 | 2018 | 91 | |
| 15 | 2018 | 7 | |
| 16 | 2018 | 22 | |
| 17 | 2017 | 17 | |
| 18 | 2017 | 28 | |
| 19 | 2014 | 13 | |
| 20 | 2013 | 53 |
About Anna Scomparin
Anna Scomparin is a scholar working on Biomaterials, Pharmaceutical Science and Molecular Medicine, having authored 47 papers that have together received 1.8k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (19 papers), Advanced biosensing and bioanalysis techniques (16 papers), Nanoparticle-Based Drug Delivery (12 papers), Nanoplatforms for cancer theranostics (10 papers), Immunotherapy and Immune Responses (8 papers), Advanced Drug Delivery Systems (5 papers), Graphene and Nanomaterials Applications (4 papers) and DNA and Nucleic Acid Chemistry (3 papers). The work is most often cited by research in Biomaterials (595 citations), Pharmaceutical Science (160 citations) and Immunology (299 citations). Anna Scomparin has collaborated with scholars based in Israel, Italy and Portugal. Frequent co-authors include Ronit Satchi‐Fainaro, Anat Eldar‐Boock, Galia Tiram, Dina Polyak, Paula Ofek, Doron Shabat, Stefano Salmaso, Adva Krivitsky, Paolo Caliceti and Shiran Ferber. Their work appears in journals such as Journal of Controlled Release, Bioconjugate Chemistry, Advanced Drug Delivery Reviews, International Journal of Pharmaceutics and Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.